The Home Depot, Inc. (HD) continued its upward trend with the stock climbing 1.82% or $2.47 to close the day at $138.07 on active trading volume of 7.03M shares, compared to its three month average trading volume of 5.23M. The Atlanta Georgia 30339 based company has been outperforming the home improvement stores group over the past 52 weeks, with the stock gaining 14.87%, compared to the industry which has advanced 11.83% over the same period. With RSI of 66.92, the stock should still continue to rise and get closer to its one year target estimate of $148.08, making it a hold for now.
The Home Depot, Inc. operates as a home improvement retailer. It operates The Home Depot stores that sell various building materials, home improvement products, and lawn and garden products, as well as provide installation, home maintenance, and professional service programs to do-it-yourself, do-it-for-me (DIFM), and professional customers. The company offers installation programs that include flooring, cabinets, countertops, water heaters, and sheds; and professional installation in various categories sold through its in-home sales programs, such as roofing, siding, windows, cabinet refacing, furnaces, and central air systems, as well as acts as a contractor to provide installation services to its DIFM customers through third-party installers. It primarily serves home owners; and renovators/remodelers, general contractors, repairmen, installers, small business owners, and tradesmen. The company also sells its products through online. As of December 31, 2015, it had 2,274 stores, including 1,977 in the United States, 182 in Canada, and 115 in Mexico. The Home Depot, Inc. was founded in 1978 and is based in Atlanta, Georgia.
Boston Scientific Corporation (BSX) fell -0.92% during last trading as the stock lost $-0.22 to finish the day at $23.68 with about 7.03M shares changing hands, compared to its three month average trading volume of 8.94M. The $32.22B market cap company, which fluctuated between $23.53 and $23.88 during the day, currently situated 51.12% above its 52 week low of $15.67 and -4.48% away from its one year high of $24.79. The RSI of 69.71 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. The company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; coronary technology products to treat atherosclerosis; intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as peripheral vessels; and structural heart therapy systems. It also provides stents, balloon catheters, wires, peripheral embolization devices, and vena cava filters used to treat peripheral disease; and biliary stents, drainage catheters, and micro-puncture sets to treat, diagnose, and ease benign and malignant tumors. In addition, the company offers cardiac rhythm management devices, such as implantable cardioverter defibrillator systems to detect and treat abnormally fast heart rhythms; implantable cardiac resynchronization therapy pacemaker systems used to treat heart failure; and medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising steerable radio frequency ablation catheters, intracardiac ultrasound catheters, diagnostic catheters, delivery sheaths, and other accessories. Further, it provides products to diagnose and treat diseases of the pulmonary and gastrointestinal conditions; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; products to treat urinary stone disease and benign prostatic hyperplasia; mid-urethral sling products, sling and graft materials, pelvic floor reconstruction kits, and suturing devices; and spinal cord stimulator systems. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
McDonald’s Corporation (MCD) saw its value decrease by -0.72% as the stock dropped $-0.88 to finish the day at a closing price of $121.38. The stock was higher in trading and has fluctuated between $110.33-$131.96 per share for the past year. The shares, which traded within a range of $119.82 to $122.08 during the day, are up by 10.63% in the past three months and down by -3.89% over the past six months. It is currently trading -0.3% below its 20 day moving average and 0.94% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $128.52 a share over the next twelve months. The current relative strength index (RSI) reading is 50.04. The technical indicator lead us to believe there will be no major movement any time soon, hold.
McDonalds Corporation operates and franchises McDonald’s restaurants in the United States, Europe, the Asia/Pacific, the Middle East, Africa, Canada, and Latin America. The company’s restaurants offer various food products, soft drinks, coffee, and other beverages. As of December 31, 2015, it operated 36,525 restaurants, including 30,081 franchised restaurants comprising 21,147 franchised to conventional franchisees, 5,529 licensed to developmental licensees, and 3,405 licensed to foreign affiliates; and 6,444 company-operated restaurants. The company has strategic partnerships with CITIC Limited, CITIC Capital, and The Carlyle Group to expand its business in Mainland China and Hong Kong. McDonalds Corporation was founded in 1940 and is based in Oak Brook, Illinois.